nodes	percent_of_prediction	percent_of_DWPC	metapath
Gadoversetamide—Gadoxetate—ABCC2—type 2 diabetes mellitus	0.00739	1	CrCbGaD
Gadoversetamide—Insomnia—Orlistat—type 2 diabetes mellitus	0.000509	0.000513	CcSEcCtD
Gadoversetamide—Malaise—Losartan—type 2 diabetes mellitus	0.000509	0.000513	CcSEcCtD
Gadoversetamide—Anxiety—Irbesartan—type 2 diabetes mellitus	0.000509	0.000512	CcSEcCtD
Gadoversetamide—Hypersensitivity—Glyburide—type 2 diabetes mellitus	0.000508	0.000512	CcSEcCtD
Gadoversetamide—Nervous system disorder—Metformin—type 2 diabetes mellitus	0.000508	0.000512	CcSEcCtD
Gadoversetamide—Thrombocytopenia—Metformin—type 2 diabetes mellitus	0.000508	0.000511	CcSEcCtD
Gadoversetamide—Dyspnoea—Valsartan—type 2 diabetes mellitus	0.000508	0.000511	CcSEcCtD
Gadoversetamide—Vertigo—Losartan—type 2 diabetes mellitus	0.000507	0.000511	CcSEcCtD
Gadoversetamide—Unspecified disorder of skin and subcutaneous tissue—Irbesartan—type 2 diabetes mellitus	0.000507	0.000511	CcSEcCtD
Gadoversetamide—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	0.000507	0.000511	CcSEcCtD
Gadoversetamide—Somnolence—Valsartan—type 2 diabetes mellitus	0.000506	0.00051	CcSEcCtD
Gadoversetamide—Syncope—Losartan—type 2 diabetes mellitus	0.000506	0.00051	CcSEcCtD
Gadoversetamide—Paraesthesia—Orlistat—type 2 diabetes mellitus	0.000505	0.000509	CcSEcCtD
Gadoversetamide—Discomfort—Irbesartan—type 2 diabetes mellitus	0.000504	0.000508	CcSEcCtD
Gadoversetamide—Skin disorder—Metformin—type 2 diabetes mellitus	0.000504	0.000507	CcSEcCtD
Gadoversetamide—Immune system disorder—Ramipril—type 2 diabetes mellitus	0.000502	0.000506	CcSEcCtD
Gadoversetamide—Hyperhidrosis—Metformin—type 2 diabetes mellitus	0.000501	0.000505	CcSEcCtD
Gadoversetamide—Dyspepsia—Valsartan—type 2 diabetes mellitus	0.000501	0.000505	CcSEcCtD
Gadoversetamide—Mediastinal disorder—Ramipril—type 2 diabetes mellitus	0.000501	0.000505	CcSEcCtD
Gadoversetamide—Dizziness—Bromocriptine—type 2 diabetes mellitus	0.000499	0.000503	CcSEcCtD
Gadoversetamide—Dry mouth—Irbesartan—type 2 diabetes mellitus	0.000499	0.000503	CcSEcCtD
Gadoversetamide—Palpitations—Losartan—type 2 diabetes mellitus	0.000499	0.000502	CcSEcCtD
Gadoversetamide—Nausea—Glimepiride—type 2 diabetes mellitus	0.000497	0.000501	CcSEcCtD
Gadoversetamide—Arrhythmia—Ramipril—type 2 diabetes mellitus	0.000496	0.0005	CcSEcCtD
Gadoversetamide—Loss of consciousness—Losartan—type 2 diabetes mellitus	0.000496	0.0005	CcSEcCtD
Gadoversetamide—Nausea—Sitagliptin—type 2 diabetes mellitus	0.000496	0.000499	CcSEcCtD
Gadoversetamide—Dyspepsia—Orlistat—type 2 diabetes mellitus	0.000495	0.000499	CcSEcCtD
Gadoversetamide—Asthenia—Glyburide—type 2 diabetes mellitus	0.000495	0.000499	CcSEcCtD
Gadoversetamide—Decreased appetite—Valsartan—type 2 diabetes mellitus	0.000495	0.000499	CcSEcCtD
Gadoversetamide—Anorexia—Metformin—type 2 diabetes mellitus	0.000494	0.000498	CcSEcCtD
Gadoversetamide—Cough—Losartan—type 2 diabetes mellitus	0.000492	0.000496	CcSEcCtD
Gadoversetamide—Urticaria—Gliclazide—type 2 diabetes mellitus	0.000492	0.000496	CcSEcCtD
Gadoversetamide—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	0.000492	0.000495	CcSEcCtD
Gadoversetamide—Fatigue—Valsartan—type 2 diabetes mellitus	0.000491	0.000495	CcSEcCtD
Gadoversetamide—Abdominal pain—Gliclazide—type 2 diabetes mellitus	0.00049	0.000494	CcSEcCtD
Gadoversetamide—Body temperature increased—Gliclazide—type 2 diabetes mellitus	0.00049	0.000494	CcSEcCtD
Gadoversetamide—Oedema—Irbesartan—type 2 diabetes mellitus	0.000489	0.000493	CcSEcCtD
Gadoversetamide—Anaphylactic shock—Irbesartan—type 2 diabetes mellitus	0.000489	0.000493	CcSEcCtD
Gadoversetamide—Decreased appetite—Orlistat—type 2 diabetes mellitus	0.000489	0.000493	CcSEcCtD
Gadoversetamide—Pruritus—Glyburide—type 2 diabetes mellitus	0.000488	0.000492	CcSEcCtD
Gadoversetamide—Mental disorder—Ramipril—type 2 diabetes mellitus	0.000487	0.000491	CcSEcCtD
Gadoversetamide—Constipation—Valsartan—type 2 diabetes mellitus	0.000487	0.000491	CcSEcCtD
Gadoversetamide—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	0.000486	0.000489	CcSEcCtD
Gadoversetamide—Fatigue—Orlistat—type 2 diabetes mellitus	0.000485	0.000489	CcSEcCtD
Gadoversetamide—Hypotension—Metformin—type 2 diabetes mellitus	0.000485	0.000488	CcSEcCtD
Gadoversetamide—Malnutrition—Ramipril—type 2 diabetes mellitus	0.000484	0.000487	CcSEcCtD
Gadoversetamide—Erythema—Ramipril—type 2 diabetes mellitus	0.000484	0.000487	CcSEcCtD
Gadoversetamide—Shock—Irbesartan—type 2 diabetes mellitus	0.000481	0.000485	CcSEcCtD
Gadoversetamide—Pain—Orlistat—type 2 diabetes mellitus	0.000481	0.000485	CcSEcCtD
Gadoversetamide—Myalgia—Losartan—type 2 diabetes mellitus	0.00048	0.000484	CcSEcCtD
Gadoversetamide—Chest pain—Losartan—type 2 diabetes mellitus	0.00048	0.000484	CcSEcCtD
Gadoversetamide—Arthralgia—Losartan—type 2 diabetes mellitus	0.00048	0.000484	CcSEcCtD
Gadoversetamide—Vomiting—Bromocriptine—type 2 diabetes mellitus	0.00048	0.000484	CcSEcCtD
Gadoversetamide—Nervous system disorder—Irbesartan—type 2 diabetes mellitus	0.00048	0.000483	CcSEcCtD
Gadoversetamide—Thrombocytopenia—Irbesartan—type 2 diabetes mellitus	0.000479	0.000483	CcSEcCtD
Gadoversetamide—Anxiety—Losartan—type 2 diabetes mellitus	0.000479	0.000482	CcSEcCtD
Gadoversetamide—Tachycardia—Irbesartan—type 2 diabetes mellitus	0.000478	0.000481	CcSEcCtD
Gadoversetamide—Rash—Bromocriptine—type 2 diabetes mellitus	0.000476	0.00048	CcSEcCtD
Gadoversetamide—Dermatitis—Bromocriptine—type 2 diabetes mellitus	0.000476	0.000479	CcSEcCtD
Gadoversetamide—Skin disorder—Irbesartan—type 2 diabetes mellitus	0.000475	0.000479	CcSEcCtD
Gadoversetamide—Tension—Ramipril—type 2 diabetes mellitus	0.000475	0.000478	CcSEcCtD
Gadoversetamide—Discomfort—Losartan—type 2 diabetes mellitus	0.000475	0.000478	CcSEcCtD
Gadoversetamide—Dysgeusia—Ramipril—type 2 diabetes mellitus	0.000474	0.000477	CcSEcCtD
Gadoversetamide—Hyperhidrosis—Irbesartan—type 2 diabetes mellitus	0.000473	0.000477	CcSEcCtD
Gadoversetamide—Headache—Bromocriptine—type 2 diabetes mellitus	0.000473	0.000476	CcSEcCtD
Gadoversetamide—Musculoskeletal discomfort—Metformin—type 2 diabetes mellitus	0.000472	0.000476	CcSEcCtD
Gadoversetamide—Diarrhoea—Glyburide—type 2 diabetes mellitus	0.000472	0.000476	CcSEcCtD
Gadoversetamide—Nervousness—Ramipril—type 2 diabetes mellitus	0.00047	0.000473	CcSEcCtD
Gadoversetamide—Dry mouth—Losartan—type 2 diabetes mellitus	0.00047	0.000473	CcSEcCtD
Gadoversetamide—Anorexia—Irbesartan—type 2 diabetes mellitus	0.000466	0.00047	CcSEcCtD
Gadoversetamide—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	0.000466	0.000469	CcSEcCtD
Gadoversetamide—Paraesthesia—Metformin—type 2 diabetes mellitus	0.000466	0.000469	CcSEcCtD
Gadoversetamide—Muscle spasms—Ramipril—type 2 diabetes mellitus	0.000465	0.000469	CcSEcCtD
Gadoversetamide—Confusional state—Losartan—type 2 diabetes mellitus	0.000464	0.000468	CcSEcCtD
Gadoversetamide—Feeling abnormal—Orlistat—type 2 diabetes mellitus	0.000464	0.000467	CcSEcCtD
Gadoversetamide—Dyspnoea—Metformin—type 2 diabetes mellitus	0.000462	0.000466	CcSEcCtD
Gadoversetamide—Somnolence—Metformin—type 2 diabetes mellitus	0.000461	0.000464	CcSEcCtD
Gadoversetamide—Anaphylactic shock—Losartan—type 2 diabetes mellitus	0.00046	0.000464	CcSEcCtD
Gadoversetamide—Oedema—Losartan—type 2 diabetes mellitus	0.00046	0.000464	CcSEcCtD
Gadoversetamide—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	0.00046	0.000463	CcSEcCtD
Gadoversetamide—Hypotension—Irbesartan—type 2 diabetes mellitus	0.000457	0.000461	CcSEcCtD
Gadoversetamide—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	0.000457	0.00046	CcSEcCtD
Gadoversetamide—Dyspepsia—Metformin—type 2 diabetes mellitus	0.000456	0.00046	CcSEcCtD
Gadoversetamide—Tremor—Ramipril—type 2 diabetes mellitus	0.000453	0.000457	CcSEcCtD
Gadoversetamide—Shock—Losartan—type 2 diabetes mellitus	0.000453	0.000456	CcSEcCtD
Gadoversetamide—Urticaria—Valsartan—type 2 diabetes mellitus	0.000452	0.000456	CcSEcCtD
Gadoversetamide—Nervous system disorder—Losartan—type 2 diabetes mellitus	0.000452	0.000455	CcSEcCtD
Gadoversetamide—Thrombocytopenia—Losartan—type 2 diabetes mellitus	0.000451	0.000454	CcSEcCtD
Gadoversetamide—Decreased appetite—Metformin—type 2 diabetes mellitus	0.000451	0.000454	CcSEcCtD
Gadoversetamide—Abdominal pain—Valsartan—type 2 diabetes mellitus	0.00045	0.000453	CcSEcCtD
Gadoversetamide—Tachycardia—Losartan—type 2 diabetes mellitus	0.000449	0.000453	CcSEcCtD
Gadoversetamide—Ill-defined disorder—Ramipril—type 2 diabetes mellitus	0.000449	0.000452	CcSEcCtD
Gadoversetamide—Nausea—Bromocriptine—type 2 diabetes mellitus	0.000448	0.000452	CcSEcCtD
Gadoversetamide—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	0.000448	0.000451	CcSEcCtD
Gadoversetamide—Fatigue—Metformin—type 2 diabetes mellitus	0.000447	0.00045	CcSEcCtD
Gadoversetamide—Urticaria—Orlistat—type 2 diabetes mellitus	0.000447	0.00045	CcSEcCtD
Gadoversetamide—Musculoskeletal discomfort—Irbesartan—type 2 diabetes mellitus	0.000446	0.000449	CcSEcCtD
Gadoversetamide—Hyperhidrosis—Losartan—type 2 diabetes mellitus	0.000445	0.000448	CcSEcCtD
Gadoversetamide—Abdominal pain—Orlistat—type 2 diabetes mellitus	0.000445	0.000448	CcSEcCtD
Gadoversetamide—Body temperature increased—Orlistat—type 2 diabetes mellitus	0.000445	0.000448	CcSEcCtD
Gadoversetamide—Asthenia—Gliclazide—type 2 diabetes mellitus	0.000445	0.000448	CcSEcCtD
Gadoversetamide—Agitation—Ramipril—type 2 diabetes mellitus	0.000445	0.000448	CcSEcCtD
Gadoversetamide—Constipation—Metformin—type 2 diabetes mellitus	0.000443	0.000447	CcSEcCtD
Gadoversetamide—Paraesthesia—Irbesartan—type 2 diabetes mellitus	0.000439	0.000443	CcSEcCtD
Gadoversetamide—Anorexia—Losartan—type 2 diabetes mellitus	0.000439	0.000442	CcSEcCtD
Gadoversetamide—Vomiting—Glyburide—type 2 diabetes mellitus	0.000439	0.000442	CcSEcCtD
Gadoversetamide—Pruritus—Gliclazide—type 2 diabetes mellitus	0.000438	0.000442	CcSEcCtD
Gadoversetamide—Malaise—Ramipril—type 2 diabetes mellitus	0.000436	0.00044	CcSEcCtD
Gadoversetamide—Dyspnoea—Irbesartan—type 2 diabetes mellitus	0.000436	0.000439	CcSEcCtD
Gadoversetamide—Rash—Glyburide—type 2 diabetes mellitus	0.000435	0.000438	CcSEcCtD
Gadoversetamide—Somnolence—Irbesartan—type 2 diabetes mellitus	0.000435	0.000438	CcSEcCtD
Gadoversetamide—Dermatitis—Glyburide—type 2 diabetes mellitus	0.000435	0.000438	CcSEcCtD
Gadoversetamide—Vertigo—Ramipril—type 2 diabetes mellitus	0.000435	0.000438	CcSEcCtD
Gadoversetamide—Syncope—Ramipril—type 2 diabetes mellitus	0.000434	0.000437	CcSEcCtD
Gadoversetamide—Headache—Glyburide—type 2 diabetes mellitus	0.000432	0.000436	CcSEcCtD
Gadoversetamide—Dyspepsia—Irbesartan—type 2 diabetes mellitus	0.000431	0.000434	CcSEcCtD
Gadoversetamide—Hypotension—Losartan—type 2 diabetes mellitus	0.00043	0.000433	CcSEcCtD
Gadoversetamide—Palpitations—Ramipril—type 2 diabetes mellitus	0.000428	0.000431	CcSEcCtD
Gadoversetamide—Feeling abnormal—Metformin—type 2 diabetes mellitus	0.000427	0.00043	CcSEcCtD
Gadoversetamide—Decreased appetite—Irbesartan—type 2 diabetes mellitus	0.000425	0.000429	CcSEcCtD
Gadoversetamide—Loss of consciousness—Ramipril—type 2 diabetes mellitus	0.000425	0.000428	CcSEcCtD
Gadoversetamide—Diarrhoea—Gliclazide—type 2 diabetes mellitus	0.000424	0.000427	CcSEcCtD
Gadoversetamide—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	0.000424	0.000427	CcSEcCtD
Gadoversetamide—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	0.000422	0.000426	CcSEcCtD
Gadoversetamide—Cough—Ramipril—type 2 diabetes mellitus	0.000422	0.000425	CcSEcCtD
Gadoversetamide—Fatigue—Irbesartan—type 2 diabetes mellitus	0.000422	0.000425	CcSEcCtD
Gadoversetamide—Musculoskeletal discomfort—Losartan—type 2 diabetes mellitus	0.00042	0.000423	CcSEcCtD
Gadoversetamide—Hypersensitivity—Valsartan—type 2 diabetes mellitus	0.000419	0.000423	CcSEcCtD
Gadoversetamide—Convulsion—Ramipril—type 2 diabetes mellitus	0.000419	0.000422	CcSEcCtD
Gadoversetamide—Constipation—Irbesartan—type 2 diabetes mellitus	0.000418	0.000422	CcSEcCtD
Gadoversetamide—Pain—Irbesartan—type 2 diabetes mellitus	0.000418	0.000422	CcSEcCtD
Gadoversetamide—Insomnia—Losartan—type 2 diabetes mellitus	0.000416	0.00042	CcSEcCtD
Gadoversetamide—Hypersensitivity—Orlistat—type 2 diabetes mellitus	0.000415	0.000418	CcSEcCtD
Gadoversetamide—Paraesthesia—Losartan—type 2 diabetes mellitus	0.000413	0.000417	CcSEcCtD
Gadoversetamide—Urticaria—Metformin—type 2 diabetes mellitus	0.000412	0.000415	CcSEcCtD
Gadoversetamide—Arthralgia—Ramipril—type 2 diabetes mellitus	0.000412	0.000415	CcSEcCtD
Gadoversetamide—Myalgia—Ramipril—type 2 diabetes mellitus	0.000412	0.000415	CcSEcCtD
Gadoversetamide—Chest pain—Ramipril—type 2 diabetes mellitus	0.000412	0.000415	CcSEcCtD
Gadoversetamide—Dyspnoea—Losartan—type 2 diabetes mellitus	0.000411	0.000414	CcSEcCtD
Gadoversetamide—Anxiety—Ramipril—type 2 diabetes mellitus	0.00041	0.000414	CcSEcCtD
Gadoversetamide—Nausea—Glyburide—type 2 diabetes mellitus	0.00041	0.000413	CcSEcCtD
Gadoversetamide—Abdominal pain—Metformin—type 2 diabetes mellitus	0.00041	0.000413	CcSEcCtD
Gadoversetamide—Dizziness—Gliclazide—type 2 diabetes mellitus	0.00041	0.000413	CcSEcCtD
Gadoversetamide—Somnolence—Losartan—type 2 diabetes mellitus	0.000409	0.000412	CcSEcCtD
Gadoversetamide—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 2 diabetes mellitus	0.000409	0.000412	CcSEcCtD
Gadoversetamide—Asthenia—Valsartan—type 2 diabetes mellitus	0.000409	0.000412	CcSEcCtD
Gadoversetamide—Discomfort—Ramipril—type 2 diabetes mellitus	0.000407	0.00041	CcSEcCtD
Gadoversetamide—Dyspepsia—Losartan—type 2 diabetes mellitus	0.000405	0.000408	CcSEcCtD
Gadoversetamide—Asthenia—Orlistat—type 2 diabetes mellitus	0.000404	0.000407	CcSEcCtD
Gadoversetamide—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	0.000403	0.000406	CcSEcCtD
Gadoversetamide—Pruritus—Valsartan—type 2 diabetes mellitus	0.000403	0.000406	CcSEcCtD
Gadoversetamide—Dry mouth—Ramipril—type 2 diabetes mellitus	0.000403	0.000406	CcSEcCtD
Gadoversetamide—Decreased appetite—Losartan—type 2 diabetes mellitus	0.0004	0.000403	CcSEcCtD
Gadoversetamide—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	0.0004	0.000403	CcSEcCtD
Gadoversetamide—Confusional state—Ramipril—type 2 diabetes mellitus	0.000398	0.000401	CcSEcCtD
Gadoversetamide—Pruritus—Orlistat—type 2 diabetes mellitus	0.000398	0.000401	CcSEcCtD
Gadoversetamide—Fatigue—Losartan—type 2 diabetes mellitus	0.000397	0.0004	CcSEcCtD
Gadoversetamide—Anaphylactic shock—Ramipril—type 2 diabetes mellitus	0.000395	0.000398	CcSEcCtD
Gadoversetamide—Oedema—Ramipril—type 2 diabetes mellitus	0.000395	0.000398	CcSEcCtD
Gadoversetamide—Vomiting—Gliclazide—type 2 diabetes mellitus	0.000394	0.000397	CcSEcCtD
Gadoversetamide—Pain—Losartan—type 2 diabetes mellitus	0.000394	0.000397	CcSEcCtD
Gadoversetamide—Constipation—Losartan—type 2 diabetes mellitus	0.000394	0.000397	CcSEcCtD
Gadoversetamide—Rash—Gliclazide—type 2 diabetes mellitus	0.000391	0.000394	CcSEcCtD
Gadoversetamide—Dermatitis—Gliclazide—type 2 diabetes mellitus	0.00039	0.000393	CcSEcCtD
Gadoversetamide—Diarrhoea—Valsartan—type 2 diabetes mellitus	0.00039	0.000392	CcSEcCtD
Gadoversetamide—Urticaria—Irbesartan—type 2 diabetes mellitus	0.000389	0.000392	CcSEcCtD
Gadoversetamide—Shock—Ramipril—type 2 diabetes mellitus	0.000388	0.000391	CcSEcCtD
Gadoversetamide—Headache—Gliclazide—type 2 diabetes mellitus	0.000388	0.000391	CcSEcCtD
Gadoversetamide—Nervous system disorder—Ramipril—type 2 diabetes mellitus	0.000387	0.00039	CcSEcCtD
Gadoversetamide—Abdominal pain—Irbesartan—type 2 diabetes mellitus	0.000387	0.00039	CcSEcCtD
Gadoversetamide—Body temperature increased—Irbesartan—type 2 diabetes mellitus	0.000387	0.00039	CcSEcCtD
Gadoversetamide—Thrombocytopenia—Ramipril—type 2 diabetes mellitus	0.000387	0.000389	CcSEcCtD
Gadoversetamide—Tachycardia—Ramipril—type 2 diabetes mellitus	0.000385	0.000388	CcSEcCtD
Gadoversetamide—Diarrhoea—Orlistat—type 2 diabetes mellitus	0.000385	0.000388	CcSEcCtD
Gadoversetamide—Skin disorder—Ramipril—type 2 diabetes mellitus	0.000384	0.000386	CcSEcCtD
Gadoversetamide—Hyperhidrosis—Ramipril—type 2 diabetes mellitus	0.000382	0.000385	CcSEcCtD
Gadoversetamide—Feeling abnormal—Losartan—type 2 diabetes mellitus	0.000379	0.000382	CcSEcCtD
Gadoversetamide—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	0.000377	0.000379	CcSEcCtD
Gadoversetamide—Dizziness—Valsartan—type 2 diabetes mellitus	0.000377	0.000379	CcSEcCtD
Gadoversetamide—Anorexia—Ramipril—type 2 diabetes mellitus	0.000376	0.000379	CcSEcCtD
Gadoversetamide—Dizziness—Orlistat—type 2 diabetes mellitus	0.000372	0.000375	CcSEcCtD
Gadoversetamide—Asthenia—Metformin—type 2 diabetes mellitus	0.000372	0.000375	CcSEcCtD
Gadoversetamide—Hypotension—Ramipril—type 2 diabetes mellitus	0.000369	0.000372	CcSEcCtD
Gadoversetamide—Nausea—Gliclazide—type 2 diabetes mellitus	0.000368	0.000371	CcSEcCtD
Gadoversetamide—Pruritus—Metformin—type 2 diabetes mellitus	0.000367	0.00037	CcSEcCtD
Gadoversetamide—Urticaria—Losartan—type 2 diabetes mellitus	0.000366	0.000369	CcSEcCtD
Gadoversetamide—Body temperature increased—Losartan—type 2 diabetes mellitus	0.000364	0.000367	CcSEcCtD
Gadoversetamide—Abdominal pain—Losartan—type 2 diabetes mellitus	0.000364	0.000367	CcSEcCtD
Gadoversetamide—Vomiting—Valsartan—type 2 diabetes mellitus	0.000362	0.000365	CcSEcCtD
Gadoversetamide—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	0.000361	0.000363	CcSEcCtD
Gadoversetamide—Musculoskeletal discomfort—Ramipril—type 2 diabetes mellitus	0.00036	0.000362	CcSEcCtD
Gadoversetamide—Rash—Valsartan—type 2 diabetes mellitus	0.000359	0.000362	CcSEcCtD
Gadoversetamide—Dermatitis—Valsartan—type 2 diabetes mellitus	0.000359	0.000361	CcSEcCtD
Gadoversetamide—Vomiting—Orlistat—type 2 diabetes mellitus	0.000358	0.00036	CcSEcCtD
Gadoversetamide—Insomnia—Ramipril—type 2 diabetes mellitus	0.000357	0.00036	CcSEcCtD
Gadoversetamide—Headache—Valsartan—type 2 diabetes mellitus	0.000357	0.000359	CcSEcCtD
Gadoversetamide—Diarrhoea—Metformin—type 2 diabetes mellitus	0.000355	0.000357	CcSEcCtD
Gadoversetamide—Rash—Orlistat—type 2 diabetes mellitus	0.000355	0.000357	CcSEcCtD
Gadoversetamide—Paraesthesia—Ramipril—type 2 diabetes mellitus	0.000355	0.000357	CcSEcCtD
Gadoversetamide—Dermatitis—Orlistat—type 2 diabetes mellitus	0.000354	0.000357	CcSEcCtD
Gadoversetamide—Headache—Orlistat—type 2 diabetes mellitus	0.000352	0.000355	CcSEcCtD
Gadoversetamide—Dyspnoea—Ramipril—type 2 diabetes mellitus	0.000352	0.000355	CcSEcCtD
Gadoversetamide—Asthenia—Irbesartan—type 2 diabetes mellitus	0.000351	0.000354	CcSEcCtD
Gadoversetamide—Somnolence—Ramipril—type 2 diabetes mellitus	0.000351	0.000354	CcSEcCtD
Gadoversetamide—Dyspepsia—Ramipril—type 2 diabetes mellitus	0.000348	0.00035	CcSEcCtD
Gadoversetamide—Pruritus—Irbesartan—type 2 diabetes mellitus	0.000346	0.000349	CcSEcCtD
Gadoversetamide—Decreased appetite—Ramipril—type 2 diabetes mellitus	0.000343	0.000346	CcSEcCtD
Gadoversetamide—Dizziness—Metformin—type 2 diabetes mellitus	0.000343	0.000345	CcSEcCtD
Gadoversetamide—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	0.000341	0.000343	CcSEcCtD
Gadoversetamide—Fatigue—Ramipril—type 2 diabetes mellitus	0.00034	0.000343	CcSEcCtD
Gadoversetamide—Hypersensitivity—Losartan—type 2 diabetes mellitus	0.000339	0.000342	CcSEcCtD
Gadoversetamide—Nausea—Valsartan—type 2 diabetes mellitus	0.000338	0.000341	CcSEcCtD
Gadoversetamide—Constipation—Ramipril—type 2 diabetes mellitus	0.000338	0.00034	CcSEcCtD
Gadoversetamide—Diarrhoea—Irbesartan—type 2 diabetes mellitus	0.000335	0.000337	CcSEcCtD
Gadoversetamide—Nausea—Orlistat—type 2 diabetes mellitus	0.000334	0.000337	CcSEcCtD
Gadoversetamide—Asthenia—Losartan—type 2 diabetes mellitus	0.00033	0.000333	CcSEcCtD
Gadoversetamide—Vomiting—Metformin—type 2 diabetes mellitus	0.00033	0.000332	CcSEcCtD
Gadoversetamide—Rash—Metformin—type 2 diabetes mellitus	0.000327	0.000329	CcSEcCtD
Gadoversetamide—Dermatitis—Metformin—type 2 diabetes mellitus	0.000327	0.000329	CcSEcCtD
Gadoversetamide—Pruritus—Losartan—type 2 diabetes mellitus	0.000326	0.000328	CcSEcCtD
Gadoversetamide—Feeling abnormal—Ramipril—type 2 diabetes mellitus	0.000325	0.000328	CcSEcCtD
Gadoversetamide—Headache—Metformin—type 2 diabetes mellitus	0.000325	0.000327	CcSEcCtD
Gadoversetamide—Dizziness—Irbesartan—type 2 diabetes mellitus	0.000324	0.000326	CcSEcCtD
Gadoversetamide—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	0.000323	0.000325	CcSEcCtD
Gadoversetamide—Diarrhoea—Losartan—type 2 diabetes mellitus	0.000315	0.000317	CcSEcCtD
Gadoversetamide—Urticaria—Ramipril—type 2 diabetes mellitus	0.000314	0.000316	CcSEcCtD
Gadoversetamide—Abdominal pain—Ramipril—type 2 diabetes mellitus	0.000312	0.000314	CcSEcCtD
Gadoversetamide—Body temperature increased—Ramipril—type 2 diabetes mellitus	0.000312	0.000314	CcSEcCtD
Gadoversetamide—Vomiting—Irbesartan—type 2 diabetes mellitus	0.000311	0.000313	CcSEcCtD
Gadoversetamide—Rash—Irbesartan—type 2 diabetes mellitus	0.000309	0.000311	CcSEcCtD
Gadoversetamide—Dermatitis—Irbesartan—type 2 diabetes mellitus	0.000308	0.000311	CcSEcCtD
Gadoversetamide—Nausea—Metformin—type 2 diabetes mellitus	0.000308	0.00031	CcSEcCtD
Gadoversetamide—Headache—Irbesartan—type 2 diabetes mellitus	0.000307	0.000309	CcSEcCtD
Gadoversetamide—Dizziness—Losartan—type 2 diabetes mellitus	0.000305	0.000307	CcSEcCtD
Gadoversetamide—Vomiting—Losartan—type 2 diabetes mellitus	0.000293	0.000295	CcSEcCtD
Gadoversetamide—Hypersensitivity—Ramipril—type 2 diabetes mellitus	0.000291	0.000293	CcSEcCtD
Gadoversetamide—Nausea—Irbesartan—type 2 diabetes mellitus	0.000291	0.000293	CcSEcCtD
Gadoversetamide—Rash—Losartan—type 2 diabetes mellitus	0.00029	0.000293	CcSEcCtD
Gadoversetamide—Dermatitis—Losartan—type 2 diabetes mellitus	0.00029	0.000292	CcSEcCtD
Gadoversetamide—Headache—Losartan—type 2 diabetes mellitus	0.000288	0.000291	CcSEcCtD
Gadoversetamide—Asthenia—Ramipril—type 2 diabetes mellitus	0.000283	0.000285	CcSEcCtD
Gadoversetamide—Pruritus—Ramipril—type 2 diabetes mellitus	0.000279	0.000281	CcSEcCtD
Gadoversetamide—Nausea—Losartan—type 2 diabetes mellitus	0.000274	0.000276	CcSEcCtD
Gadoversetamide—Diarrhoea—Ramipril—type 2 diabetes mellitus	0.00027	0.000272	CcSEcCtD
Gadoversetamide—Dizziness—Ramipril—type 2 diabetes mellitus	0.000261	0.000263	CcSEcCtD
Gadoversetamide—Vomiting—Ramipril—type 2 diabetes mellitus	0.000251	0.000253	CcSEcCtD
Gadoversetamide—Rash—Ramipril—type 2 diabetes mellitus	0.000249	0.000251	CcSEcCtD
Gadoversetamide—Dermatitis—Ramipril—type 2 diabetes mellitus	0.000249	0.000251	CcSEcCtD
Gadoversetamide—Headache—Ramipril—type 2 diabetes mellitus	0.000247	0.000249	CcSEcCtD
Gadoversetamide—Nausea—Ramipril—type 2 diabetes mellitus	0.000235	0.000236	CcSEcCtD
